Trevi Therapeutics, Inc.

TRVI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$34,097$32,397$12,589$36,830
Short-Term Investments$73,525$50,574$107,921$0
Receivables$532$0$0$241
Inventory$0$0$0$0
Other Curr. Assets$1,274$4,576$2,106$886
Total Curr. Assets$109,428$87,547$122,616$37,957
Property Plant & Equip (Net)$1,229$1,559$194$184
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$243$297$205$334
Total NC Assets$1,472$1,856$399$518
Other Assets$0$0$0$0
Total Assets$110,900$89,403$123,015$38,475
Liabilities
Payables$3,414$1,809$2,857$2,849
Short-Term Debt$285$306$7,025$5,953
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,810$3,709$3,518$3,922
Total Curr. Liab.$10,509$5,824$13,400$12,724
LT Debt$747$1,032$2,153$8,676
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$3$0
Total NC Liab.$747$1,032$2,156$8,676
Other Liabilities$0$0$0$0
Cap. Leases$1,032$1,338$27$144
Total Liabilities$11,256$6,856$15,556$21,400
Equity
Pref Stock$0$0$0$0
Common Stock$94$68$60$29
Retained Earnings-$287,045-$239,134-$210,069-$180,917
AOCI$61-$29-$122$0
Other Equity$386,534$321,642$317,590$197,963
Total Equity$99,644$82,547$107,459$17,075
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$110,900$89,403$123,015$38,475
Net Debt-$33,065-$31,059-$3,411-$22,201